Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

VNDA

+ Watchlist+ Portfolio

Vanda Pharmaceuticals Inc.

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$3.81
52-Week Range
$3.57 – $9.94
Market Cap
$226.76M
P/E (TTM)
—
EPS (TTM)
-4.62
Dividend Yield
0.00%
Advanced Metrics
Price/Book
1.13
PEG Ratio
2.23
Return on Equity
-82.55%
Return on Assets
-22.61%
Gross Margin
93.59%
Operating Margin
-77.59%
Profit Margin
-119.87%
Current Ratio
1.54
Debt/Equity
0.11
Total Debt
$21.97M
Free Cash Flow
$-85.87M
Revenue Growth
24.10%
Earnings Growth
—
Enterprise Value
$108.24M

Market Snapshot

About

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for central nervous system disorders. The company markets treatments for conditions including non-24-hour sleep-wake disorder and nighttime sleep disturbances in totally blind individuals.